Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dunne

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Iscience|September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signalingNiamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
Cells|September 28, 2023
PLAC8-Mediated Activation of NOX4 Signalling Restores Angiogenic Function of Endothelial Colony-Forming Cells in Experimental HypoxiaShun Hay Pun, Karla M O'Neill, Kevin S Edgar, et al.
Cancer Research Communications|July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional SignaturesUmair Mahmood, Andrew Blake, Sanjay Rathee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Gynecologic Oncology|September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinomaJames P Beirne, Darragh G McArt, Aideen Roddy, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Journal for Immunotherapy of Cancer|October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axisAoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.
Iscience|March 30, 2026
Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancerEoghan J Mulholland-Illingworth, Joshua W Moore, Muyang Lin, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Iscience|September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signalingNiamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
Cells|September 28, 2023
PLAC8-Mediated Activation of NOX4 Signalling Restores Angiogenic Function of Endothelial Colony-Forming Cells in Experimental HypoxiaShun Hay Pun, Karla M O'Neill, Kevin S Edgar, et al.
Cancer Research Communications|July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional SignaturesUmair Mahmood, Andrew Blake, Sanjay Rathee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Gynecologic Oncology|September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinomaJames P Beirne, Darragh G McArt, Aideen Roddy, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Journal for Immunotherapy of Cancer|October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axisAoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.
Iscience|March 30, 2026
Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancerEoghan J Mulholland-Illingworth, Joshua W Moore, Muyang Lin, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Pageof 14